cardiotox wellknown side effect doxorubicin do meghan lead phenomenon still complete clear predict druginduc defunct onset difficult lang base detect cardiac troponin can circus marker heart damage last year sever investing focus possible involve microrna mira doxinduc toxic vitro contrast result recent group employ anim model mimic patient conduit investing biology pathway aperture identify diagnose marker review studi investing express rodent doxtreat also discus data two public india use mira biomass unfortun limit inform derive select method candidatemirna heterogen ass greatly hamper novelty robust find nevertheless least one mir show good potent early biomass drugged sure help narrow gap basic research clinic practice despite issue include elev lessthanoptim obtain far nonetheless assoc patientsbas prelim may key address mani unansw question regard pathophysiolog 